Oxymetazoline Hydrochloride
Who holds supplier records for Oxymetazoline Hydrochloride? 4 organisations hold a current record for Oxymetazoline Hydrochloride: an active US FDA Type II Drug Master File or a CEP. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3) and Germany (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Oxymetazoline Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/oxymetazoline-hydrochloride
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
3 of the 4 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Oxymetazoline Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHGermanyCEP Company GMP cert on recordActive DMF 8940 · latest filing Jan 1991
- CTX LIFE SCIENCES PVT LTDIndiaActive DMF 22401 · latest filing Dec 2008
- IndiaCEP Company GMP cert on record
- IndiaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (3)
Certificates of Suitability on the EDQM register for Oxymetazoline Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 4 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| COHANCE LIFESCIENCES LIMITED Mumbai | IN | CEP 2025-091 - Rev 00 Oxymetazoline hydrochloride | Apr 2026 | — |
| CTX LIFESCIENCES PVT. LIMITED Surat | IN | CEP 2008-324 - Rev 04 Oxymetazoline hydrochloride | Mar 2026 | — |
| SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH Minden | DE | R1-CEP 2008-064 - Rev 02 Oxymetazoline hydrochloride | Jan 2021 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Oxymetazoline Hydrochloride is a sympathomimetic amine that acts as a selective alpha-1 adrenergic receptor agonist and a partial alpha-2 adrenergic receptor agonist, used as a topical decongestant. It is commonly used to relieve nasal congestion in conditions such as allergic rhinitis and sinusitis.
Chemical identity
- IUPAC name
- 6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol;hydrochloride
- Canonical SMILES
- CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C.Cl
- InChIKey
- BEEDODBODQVSIM-UHFFFAOYSA-N
- Synonyms
- Afrin API, agn-199201, nsc-757254, ocuclear, oxymetazoline hcl, rhofade, sch 9384, sch-9384, upneeq, visine l.r.
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Vasoconstrictor
- Physiologic effect
- Increased Sympathetic Activity; Vasoconstriction
- Chemical structure
- Imidazolines
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Oxymetazoline Hydrochloride?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Oxymetazoline Hydrochloride: SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH (Germany), CTX LIFE SCIENCES PVT LTD (India), COHANCE LIFESCIENCES LTD (India) and Ctx Lifesciences (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Oxymetazoline Hydrochloride Drug Master Files are active?
SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH (DMF 8940) and CTX LIFE SCIENCES PVT LTD (DMF 22401). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Oxymetazoline Hydrochloride have a European Certificate of Suitability?
Yes. 3 organisations hold a valid CEP for Oxymetazoline Hydrochloride on the EDQM register, including COHANCE LIFESCIENCES LIMITED Mumbai (IN), CTX LIFESCIENCES PVT. LIMITED Surat (IN) and SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH Minden (DE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Oxymetazoline Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Oxymetazoline Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.